JUPITER NEUROSCIENCES, INC.

Pharmaceutical Preparations

JUNS Pharmaceuticals & Biotechnology People in Pharmaceuticals & Biotechnology SEC CIK 0001679628 ↗

Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.

Market capitalisation
$4.02M
770,081 shares Covers every share class this company has on file.
Insiders on file
1
people who have filed Form 3, 4 or 5 naming this issuer
Value of insider-held stock
$1.17M
from the holdings reported on Forms 3/4/5; this figure has no separate as-of date on file
Insider-held share of market cap
29.06%
insider-held value divided by market capitalisation

What JUPITER NEUROSCIENCES, INC. reports

Revenue and net income below are for fiscal period FY2025, the period label carried by this company’s own annual XBRL filings to the SEC. Fiscal years do not line up between companies — one company’s FY2026 can cover much the same months as another’s FY2025 — so compare the periods, not just the numbers.

Revenue
$21.8K
FY2025 annual revenue, from this company’s own annual XBRL filings to the SEC
Net income
-$8.64M
FY2025 a loss for the period, from this company’s own annual XBRL filings to the SEC
Employees
5
Yahoo Finance
Where the employee count comes from

Headcount comes from Yahoo Finance, not from a filing. The date beside it is the day we retrieved the figure — it is not the date the company counted its staff, and Yahoo does not publish that date. Unlike the SEC filings behind the other figures on this page, this one carries no open licence, so we publish the number and nothing else from that source.

Insiders at JUPITER NEUROSCIENCES, INC.

Shares is what each person last reported holding here.

Everyone below has filed at least one insider report against this company.

Value is that share count priced at the same closing price used everywhere else on this site. A row priced from only some of a person’s securities says so — we do not quietly present a partial sum as a complete one.

People who file insider reports against JUPITER NEUROSCIENCES, INC..
Insider Reported role Shares Value Last action
Alexander Gustaf Erik Rosen Other Executive 356,250 $1.17M M Option exercise or conversion Jun 2, 2025 position reported

Events from filings

Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.

JUPITER NEUROSCIENCES, INC. (JUNS) filed a Form 8-K under Item 5.02 (directors and officers) on Aug 27, 2026

Director or officer change filing

The company filed a current report that includes Item 5.02, the item used to report departures, elections or appointments of directors and certain officers, and related pay arrangements. We record only that this filing exists: we have not extracted who left, who joined or whose role changed. Open the filing to read it.

Form 8-K filed Aug 27, 2026, items 1.01, 5.02, 8.01, 9.01. SEC filing ↗

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Recent insider transactions

Of the 16 rows we hold, 9 are open-market purchases (P) and 0 open-market sales — the only codes we count as buying or selling.

The rest — awards, shares withheld to pay tax, option exercises, gifts and so on — follow from an employment contract or a transfer arranged off-market, not from a decision to buy or sell, so counting them would turn this into a pay table.

A price of 0.00 is a real reported figure on gifts (G) and share awards (A) — not a gap in our data.

Insider transactions disclosed to the SEC for JUPITER NEUROSCIENCES, INC., newest first, each with the filing behind it.
Date Insider Transaction Shares Price Value Filing
Mar 2, 2026 Marshall A Hayward M Option exercise or conversion 225,000 $0.00 $0 SEC filing ↗
Jul 1, 2025 Christer Rosen P Open-market purchase 3,100 $1.02 $3.2K SEC filing ↗
Jul 1, 2025 Christer Rosen P Open-market purchase 500 $1.01 $505 SEC filing ↗
Jun 30, 2025 Christer Rosen P Open-market purchase 1,450 $1.02 $1.5K SEC filing ↗
Jun 30, 2025 Christer Rosen P Open-market purchase 1,000 $0.98 $980 SEC filing ↗
Jun 30, 2025 Christer Rosen P Open-market purchase 2,000 $1.01 $2.0K SEC filing ↗
Jun 30, 2025 Christer Rosen P Open-market purchase 700 $1.03 $721 SEC filing ↗
Jun 30, 2025 Christer Rosen P Open-market purchase 1,500 $1.04 $1.6K SEC filing ↗
Jun 30, 2025 Christer Rosen P Open-market purchase 1,000 $1.05 $1.1K SEC filing ↗
Jun 27, 2025 Christer Rosen P Open-market purchase 166 $1.06 $176 SEC filing ↗
Jun 2, 2025 Alexander Gustaf Erik Rosen M Option exercise or conversion 96,608 $0.00 $0 SEC filing ↗
Jun 2, 2025 Alexander Gustaf Erik Rosen M Option exercise or conversion 164,553 $0.00 $0 SEC filing ↗
Jun 2, 2025 Marshall A Hayward M Option exercise or conversion 399,402 $0.00 $0 SEC filing ↗
Jun 2, 2025 Marshall A Hayward M Option exercise or conversion 389,793 $0.00 $0 SEC filing ↗
Jun 2, 2025 Christer Rosen M Option exercise or conversion 476,070 $0.00 $0 SEC filing ↗
Jun 2, 2025 Christer Rosen M Option exercise or conversion 497,396 $0.00 $0 SEC filing ↗

From SEC Form 4 filings. Every row links to the filing it came from. How we calculate this.

What a Form 4 is

The report an officer, director or large shareholder must file after trading their own company’s stock.

Think a number here is wrong? Open the linked filing and compare — how to report it.

Sources and technical notes

Every figure on this page comes from filings to the U.S. SEC via EDGAR. Nothing here is estimated, and nothing is taken from press coverage or company websites.

Share count: cover page of the latest filing (dei:EntityCommonStockSharesOutstanding), taken from JUPITER NEUROSCIENCES, INC.’s own filings and multiplied by our closing price. Full method.

What that share count means

the share count the company itself prints on the cover of its most recent filing, as of the date it signed that filing.

We do not take a market cap from a data vendor, and we do not estimate one: the figure is a share count from JUPITER NEUROSCIENCES, INC.’s own SEC filings multiplied by the closing price we hold for the same stock.